Investors

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

Homology Medicines is focused on advancing our genetic medicines platform as one-time treatments and potential cures for patients with rare diseases

SEC Filing Details

Document Details

Form
Filing Date
Jan 20, 2023
Document Date
Mar 2, 2022
Form Description
An amendment to a 3 filing. Non-EDGAR filing
Filing Group
3,4,5
Company
Homology Medicines, Inc.
Issuer
Homology Medicines, Inc.
Filer
BLUM MICHAEL LEE